1. Lin R, McDonald G, Jolly T, Batten A, Chacko B. A Systematic Review of Prophylactic Anticoagulation in Nephrotic Syndrome. Kidney Int Rep, 2020. 5, 435–447; https://doi.org/10.1016/j.ekir.2019.12.001
2. Scheres LJJ, Lijfering WM, Cannegieter SC. Current and future burden of venous thrombosis: not simply predictable. Res Pract Thromb Haemost. 2018. 2:199–208. Doi: 10.1002/rth2.12101
3. Krishna K, Hiremath S, Lakade S, Davakhar S. Acute Myocardial Infarction in Nephrotic Syndrome. JAPI, 2015. https://www.japi.org/q274c434/acute-myocardial-infarction-in-nephrotic-syndrome#.YYnf_2niQqQ.link
4. Thendiono E. Clinical Conundrum of anticoagulation/antiplatelet in nephrotic syndrome: case report. Poster Presentations. Nephrology, 2021. 26:32-55. https://doi.org/10.1111/nep.13944
5. Xie L, Tang Y, Liu J, et al. Acute myocardial infarction in patients of nephrotic syndrome: a case series. J Geriatr Cardiol. 2017;14(7):481-484. doi:10.11909/j.issn.1671-5411.2017.07.009
6. Barbour SJ, Greenwald A, Djurdjev O, et al. Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis. Kidney Int, 2012. 81:190–195. Doi: 10.1038/ki.2011.312.Epub 2011 Sep 14
7. Kumar S, Chapagain A, Nitsch D, Yaqoob MM. Proteinuria and hypoalbuminemia are risk factors for thromboembolic events in patients with idiopathic membranous nephropathy: an observational study. BMC Nephrol, 2012. 13:107. Doi:10.1186/1471-2369-13-107
8. Li S-J, Guo J-Z, Zuo K, et al. Thromboembolic complications in membranous nephropathy patients with nephrotic syndrome–a prospective study. Thromb Res, 2012. 130:501–505.doi: 10.1016/j.thromres.2012.04.015.Epub 2012 May 26
9. Lionaki S, Derebail VK, Hogan SL, et al. Venous thromboembolism in patients with membranous nephropathy. Clin J Am Soc Nephrol, 2012. 7:43–51.doi: 10.2215/CJN.04250511
10. Zou PM, Li H, Cai JF, et al. A cohort study of incidences and risk factors for thromboembolic events in patients with idiopathic membranous nephropathy. Chin Med Sci J, 2018. 33: 91–99.doi: 10.24920/11809
11. Fenton A, Smith SW, Hewins P. Adult minimal-change disease: observational data from a UK centre on patient characteristics, therapies, and outcomes. BMC Nephrol, 2018. 19:207 doi: 10.1186/s12882-018-0999-x
12. Li SJ, Tu YM, Zhou CS, et al. Risk factors of venous thromboembolism in focal segmental glomerulosclerosis with nephrotic syndrome. Clin Exp Nephrol, 2016. 20:212–217. Doi: 10.1007/s10157-015-1149-4. Epub 2015 Jul 29
13. Maas RJ, Deegens JK, Beukhof JR, et al. The clinical course of minimal change nephrotic syndrome with onset in adulthood or late adolescence: a case series. Am J Kidney Dis, 2017. 69:637–646. Doi: 10.1053/j.ajkd.2016.10.032. Epub 2017 jan 12
14. SahinM, Ozkurt S, Degirmenci NA, et al. Assessment of genetic risk factors for thromboembolic complications in adults with idiopathic nephrotic syndrome. Clin Nephrol, 2013. 79:454–462. Doi: 10.5414/CN107863
15. Ismail G, Mircescu G, Ditoiu AV, et al. Risk factors for predicting venous thromboembolism in patients with nephrotic syndrome: focus on haemostasis-related parameters. Int.Urol. Nephrol, 2014. 46:787–792.doi: 10.1007/s11255-013-0574-0.
16. Gyamlani G, Molnar MZ, Lu JL, et al. Association of serum albumin level and venous thromboembolic events in a large cohort of patients with nephrotic syndrome. Nephrol Dial Transplant, 2017. 32:157–164. Doi:10.1093/ndt/gfw227
17. Lee T, Biddle AK, Lionaki S, et al. Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy. Kidney Int, 2014. 85:1412–1420. Doi: 10.1038/ki.2013.476. Epub 2013 Dec 11
18. Fauchier L, Chaize G, Gaudin AF, et al. Predictive ability of HAS-BLED, HEMORR2HAGES, and ATRIA bleeding risk scores in patients with atrial fibrillation. A French nationwide cross-sectional study. Int J Cardiol, 2016. 217:85–91. Doi: 10.1016/j.ijcard.2016.04.173
19. Medjeral-Thomas N, Ziaj S, Condon M, et al. Retrospective analysis of a novel regimen for the prevention of venous thromboembolism in nephrotic syndrome. Clin J Am Soc Nephrol, 2014. 9:478–483. Doi: 10.2215/CJN.07190713. Epub 2013 Dec 12
20. Kelddal S, Nykjær KM, Gregersen JW, Birn H. Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications. BMC Nephrol, 2019. 20:139. https://doi.org/10.1186/s12882-019-1336-8
21. Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO clinical practice guideline for glomerulonephritis. 2020. https://kdigo.org/wp-content/uploads/2017/02/KDIGO-GN-GL-Public-Review-Draft_1-June-2020.pdf